NLRP3 and Hepatic fibrosis: Upregulation of IL-16 and IL-17 is mediated by the NF-κB pathway, and maturation of IL-1β via the NLRP3 inflammasome triggers HSC activation with the consequent deposition of an increased amount of ECM, producing liver fibrosis.